Skip to main content

Scott Randal W.

In the past year, 3 open-market sale filings worth $2.09M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$2.09M
3 filings
Net
−$2.09M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Scott Randal W. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BBIO BridgeBio Pharma, Inc.

Director8 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 19, 2026 (view filing)May 154 daysScott Randal W.DirectorSSale−10.0K$67.15−$671.5K−46.3%11.6K after4 lots10b5-1
Feb 18, 2026 (view filing)Feb 171 dayScott Randal W.DirectorSSale−10.0K$75.46−$754.6K−46.3%11.6K after3 lots10b5-1
Nov 19, 2025 (view filing)Nov 172 daysScott Randal W.DirectorSSale−10.0K$66.65−$666.5K−46.3%11.6K after2 lots10b5-1
Jun 5, 2024 (view filing)Jun 3-42 daysScott Randal W.DirectorSSale−2.50K$30.32−$75.8K−38.5%4.00K after3 lots10b5-1
Mar 5, 2024 (view filing)Mar 14 daysScott Randal W.DirectorSSale−2.50K$34.00−$85.0K−27.8%6.50K after10b5-1
Dec 20, 2023 (view filing)Dec 182 daysScott Randal W.DirectorSSale−2.00K$40.00−$80.0K−18.2%9.00K after10b5-1
Dec 5, 2023 (view filing)Dec 14 daysScott Randal W.DirectorSSale−2.50K$29.40−$73.5K−18.5%11.0K after2 lots10b5-1
Sep 7, 2023 (view filing)Sep 52 daysScott Randal W.DirectorSSale−2.50K$30.00−$75.0K−15.6%13.5K after10b5-1